Diflucan Generics Launch Following Expiration Of Pfizer Exclusivity
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA approves numerous ANDAs for tablet, oral suspension and injectable forms of the antifungal upon expiration of Diflucan's six-month pediatric extension. Pfizer is marketing its own generic through its Greenstone subsidiary.